A reassuring result that fuels her role as her own advocate

Meet Patricia, a cancer survivor who grew up in Philadelphia and later relocated to Virginia. A routine eye exam turned up what her doctor described as a large freckle; three months later, it had become a tumor, and she was referred to a retina specialist. After being diagnosed with ocular melanoma and starting plaque therapy, Patricia’s doctor recommended Castle Biosciences’ DecisionDx-UM testing, using a biopsy taken during her procedure to assess her risk of metastatic disease. The result — Class 1A, with a 3% chance of metastasis — brought welcome reassurance. For Patricia, having that information reinforced her belief that patients and providers should make care decisions together, and it continues to shape her outlook as she looks forward to a long, active future.